What this trial studies
This study was conducted to determine the effects of mindfulness-based self-compassion training for menopausal women on their genital self-image and self-anger. Materials and Methods: This study was randomized with 126 menopausal women (study group n=63, control group n=63) between June 2024 and February 2025. Mindfulness-Based Self-Compassion Training (MBSCT) was applied in groups of 10 and 11 participants, twice a week, for 8 sessions of 40 minutes. Data were obtained using the Personal Information Form, Female Genital Self-Image Scale (FGSIS), and DSM-V Level II Anger Scale.
Conditions in scope
- Menopausal; Crisis
- Self-Compassion
- Image, Body
- Anger
Interventions
- Mindfulness-Based Self-Compassion Training (Behavioral) — Mindfulness-Based Self-Compassion Training is a very comprehensive approach that addresses the awareness and acceptance of individuals towards their bodies, as well as encouraging them to live a conscious life. Studies found that self-compassion increases well-being during menopause (Brown, 2015; Arab…
Who can join
All sexes · Ages 18 Years and up · Accepts healthy volunteers.
Inclusion criteria
- Being between 45 and 70 years old
- Having no hearing problems
- Being at menopause in the last year
- Having no psychiatric illness
- Having natural menopause
- Not receiving hormone replacement therapy.
Exclusion criteria
- Those who did not attend two or more training sessions during the study were excluded from the study.
- Those who entered menopause surgically and received hormone/replacement therapy during the process were not included in the study.
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Malatya | Family Health Center | Unknown |
Status & timeline
- Overall status: Completed
- Study type: Interventional
- Phase: N/A
- Start date: 2024-06-15
- Primary completion: 2024-06-15
- Last update posted: 2025-04-24
- First posted: 2025-04-24
Sponsor & contact
Lead sponsor: Tarsus University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Female Genital Self-Image Scale (FGSIS) (baseline and after 8 weeks)
The Female Genital Self-Image Scale (FGSIS) was developed by Herbenick and Reece (2010) in the United States to measure women's genital self-perceptions.
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT06942169 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.